USP Center in Ghana Receives International Lab Accreditation - Pharmaceutical Technology

Latest Issue
PharmTech

Latest Issue
PharmTech Europe

USP Center in Ghana Receives International Lab Accreditation


The US Pharmacopeial Convention (USP) has announced that its Center for Pharmaceutical Advancement and Training has received a top international laboratory accreditation. Launched in May 2013 to promote access to good quality medicines, the center is one of the only few laboratories in Sub-Saharan Africa to meet internationals standards in conducting quality control testing of medicines. The center serves all Sub-Saharan Africa—a region facing serious health issues and a proliferation of substandard and counterfeit medicines.

“We serve as a resource to countries throughout Sub-Saharan Africa by equipping regulatory authorities, manufacturers, quality control professionals, and others in the pharmaceutical industry with knowledge and skills to help ensure good quality medicines,” said Patrick Lukulay, PhD, vice-president for the USP department overseeing this effort, in a press release.

“Having an internationally accredited laboratory available as a training facility is a tremendous resource for the entire region,” said Lukulay. “The ISO 17025 accreditation, which came in record time, demonstrates the quality of our programs, the dedication of our staff in Ghana and USP’s commitment to global health.”

The center, located in Accra, Ghana, received the ISO 17025 accreditation from ACLASS, one of the three brands of the ANSI-ASQ National Accreditation Board, an internationally recognized body responsible for granting ISO/IEC accreditations to high quality testing and calibration laboratories. Preparations for obtaining the lab accreditation took place as staff was conducting training programs for regulators and manufacturers in quality control, GMPs, and dossier evaluation.

Source: USP.org

ADVERTISEMENT

blog comments powered by Disqus
LCGC E-mail Newsletters

Subscribe: Click to learn more about the newsletter
| Weekly
| Monthly
|Monthly
| Weekly

Survey
FDASIA was signed into law two years ago. Where has the most progress been made in implementation?
Reducing drug shortages
Breakthrough designations
Protecting the supply chain
Expedited reviews of drug submissions
More stakeholder involvement
Reducing drug shortages
70%
Breakthrough designations
4%
Protecting the supply chain
17%
Expedited reviews of drug submissions
2%
More stakeholder involvement
7%
View Results
Eric Langerr Outsourcing Outlook Eric LangerTargeting Different Off-Shore Destinations
Cynthia Challener, PhD Ingredients Insider Cynthia ChallenerAsymmetric Synthesis Continues to Advance
Jill Wechsler Regulatory Watch Jill Wechsler Data Integrity Key to GMP Compliance
Sean Milmo European Regulatory WatchSean MilmoExtending the Scope of Pharmacovigilance Comes at a Price
From Generics to Supergenerics
CMOs and the Track-and-Trace Race: Are You Engaged Yet?
Ebola Outbreak Raises Ethical Issues
Better Comms Means a Fitter Future for Pharma, Part 2: Realizing the Benefits of Unified Communications
Better Comms Means a Fitter Future for Pharma, Part 1: Challenges and Changes

Click here